NHS Breast Screening - Support for management of Very High Risk (VHR) Women

he right time. Current national guidelines recommend that screening should start 8 years after radiotherapy to breast tissue or at age 25 or 30 (depending on circumstances), whichever occurs later. In addition to making sure that screening appointments arrive at the right time, BARD will allow monit

oring of the effectiveness of screening. There will be a small number of women who have received radiotherapy to breast tissue as part of a treatment plan for diagnoses other than lymphoma. In these instances, the BARD non-lymphoma patient